VEGF and Delta-Notch: Interacting Signalling Pathways in Tumour Angiogenesis
Author Information
Author(s): Gavin Thurston, J. Kitajewski
Primary Institution: Regeneron Pharmaceuticals; Herbert Irving Comprehensive Cancer Center, Columbia University
Hypothesis
The study explores the interaction between the VEGF and Delta-Notch pathways in tumor angiogenesis.
Conclusion
The VEGF pathway is crucial for angiogenesis, but the Delta-Notch pathway also plays a significant role in shaping vascular responses.
Supporting Evidence
- Blocking the VEGF pathway is currently the best-validated approach to inhibit tumor angiogenesis.
- Not all tumors respond to VEGF blockers, indicating the need for alternative therapeutic targets.
- Dll4 was identified as a new target in tumor angiogenesis, interacting with the VEGF pathway.
Takeaway
This study looks at how two important pathways help tumors grow by forming new blood vessels. One pathway helps start the process, while the other helps decide how it should happen.
Methodology
The review summarizes existing knowledge on the VEGF and Delta-Notch pathways and their interactions in tumor angiogenesis.
Limitations
The review is based on existing literature and may not cover all recent findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website